Research Paper Volume 16, Issue 9 pp 8086—8109
Constructing a novel prognostic model for triple-negative breast cancer based on genes associated with vasculogenic mimicry
Figure 5. Differences in the immune cells across various groups. (A) The distribution proportion of immune cell abundance across all samples. (B) Differences in the abundance of immune cells between the high-risk and low-risk groups. (C) The correlation between prognostic genes and immune cells displays significant differences between the high-risk and low-risk groups. (D) Employing the SubMap method allowed an indirect estimation of the responsiveness to PD-1 and CTLA-4 immunotherapies in the high-risk and low-risk patient clusters.